New study reveals hidden heart risks of common breast cancer drug
NCT ID NCT06781762
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study tracks 40 women with hormone-positive breast cancer who are starting aromatase inhibitor therapy, comparing them to healthy women of similar age and weight. Researchers want to understand how this common treatment affects the heart, blood vessels, metabolism, and lifestyle in the first 6 months. The goal is to identify early warning signs of heart problems so doctors can better protect patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER FEMALES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Toronto
RECRUITINGToronto, Ontario, M5S2C9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.